Russell Investments Group’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-61,075
| Closed | -$675K | – | 3660 |
|
2023
Q2 | $675K | Sell |
61,075
-12,731
| -17% | -$141K | ﹤0.01% | 2112 |
|
2023
Q1 | $991K | Buy |
73,806
+12,138
| +20% | +$163K | ﹤0.01% | 1965 |
|
2022
Q4 | $763K | Buy |
61,668
+7,065
| +13% | +$87.4K | ﹤0.01% | 2111 |
|
2022
Q3 | $760K | Buy |
54,603
+5,717
| +12% | +$79.6K | ﹤0.01% | 2060 |
|
2022
Q2 | $674K | Sell |
48,886
-4,499
| -8% | -$62K | ﹤0.01% | 2136 |
|
2022
Q1 | $867K | Sell |
53,385
-15,460
| -22% | -$251K | ﹤0.01% | 2021 |
|
2021
Q4 | $1.12M | Sell |
68,845
-8,192
| -11% | -$133K | ﹤0.01% | 2089 |
|
2021
Q3 | $1.14M | Sell |
77,037
-2,446
| -3% | -$36.3K | ﹤0.01% | 2132 |
|
2021
Q2 | $1.59M | Buy |
79,483
+29,277
| +58% | +$585K | ﹤0.01% | 2054 |
|
2021
Q1 | $1.16M | Sell |
50,206
-71,235
| -59% | -$1.64M | ﹤0.01% | 2185 |
|
2020
Q4 | $3M | Sell |
121,441
-62,772
| -34% | -$1.55M | 0.01% | 1536 |
|
2020
Q3 | $7.64M | Buy |
184,213
+142,310
| +340% | +$5.9M | 0.02% | 910 |
|
2020
Q2 | $2.01M | Buy |
41,903
+22,043
| +111% | +$1.06M | ﹤0.01% | 1635 |
|
2020
Q1 | $1.25M | Sell |
19,860
-701
| -3% | -$44.1K | ﹤0.01% | 1735 |
|
2019
Q4 | $2.55M | Buy |
20,561
+2,407
| +13% | +$298K | ﹤0.01% | 1590 |
|
2019
Q3 | $1.2M | Buy |
+18,154
| New | +$1.2M | ﹤0.01% | 1923 |
|
2018
Q1 | – | Sell |
-30
| Closed | -$2K | – | 3029 |
|
2017
Q4 | $2K | Hold |
30
| – | – | ﹤0.01% | 2945 |
|
2017
Q3 | $2K | Sell |
30
-14,062
| -100% | -$937K | ﹤0.01% | 2927 |
|
2017
Q2 | $1.71M | Sell |
14,092
-591
| -4% | -$71.5K | ﹤0.01% | 1821 |
|
2017
Q1 | $1.66M | Buy |
14,683
+1,600
| +12% | +$181K | ﹤0.01% | 1837 |
|
2016
Q4 | $1.43M | Buy |
+13,083
| New | +$1.43M | ﹤0.01% | 1996 |
|